A common underlying cause is a latent, i.e. showing no clinical symptoms, chronic inflammation of the endometrium. The EMMA test identifies imbalances in the microbiome, while the ALICE test pinpoints the specific bacteria responsible for the inflammatory condition. A one-time endometrial biopsy is required for both tests, which significantly accelerates introduction of the appropriate treatment and preparation of the patient for another in vitro procedure.
In cases where the patient shows symptoms of endometrial inflammation, such as discharge or abdominal pain, only the ALICE test is conducted. This test identifies the specific bacteria responsible for this condition, which allows for the implementation of treatment with targeted antibiotics.